Kala Jayaram

C-Type Natriuretic Peptide Analogue Therapy in Children with Achondroplasia

Ravi Savarirayan, Melita Irving, Carlos A. Bacino et al. · New England Journal of Medicine · 2019 · 219 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +6

Once-daily, subcutaneous vosoritide therapy in children with achondroplasia: a randomised, double-blind, phase 3, placebo-controlled, multicentre trial

Ravi Savarirayan, Louise Tofts, Melita Irving et al. · The Lancet · 2020 · 198 citations

Medicine, Pediatrics, Pharmacotherapy +2

Safe and persistent growth-promoting effects of vosoritide in children with achondroplasia: 2-year results from an open-label, phase 3 extension study

Ravi Savarirayan, Louise Tofts, Melita Irving et al. · Genetics in Medicine · 2021 · 99 citations · Full text

Medicine, Orthopedic Surgery, Pharmacotherapy +10

Pharmacokinetics and Exposure–Response of Vosoritide in Children with Achondroplasia

Ming Liang Chan, Yulan Qi, Kevin Larimore et al. · Clinical Pharmacokinetics · 2021 · 39 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

A study on the safety and efficacy of reveglucosidase alfa in patients with late-onset Pompe disease

Barry J. Byrne, Tarekegn Geberhiwot, Bruce A. Barshop et al. · Orphanet Journal of Rare Diseases · 2017 · 38 citations · Full text

Life Sciences, Pharmacokinetics, Pharmacotherapy +11